Yannick Le Bris

Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann et al. · Blood · 2022 · 75 citations · Full text

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of <i>ASXL1</i> mutations: a FIM study

Damien Luque Paz, Jérémie Riou, Emmanuelle Verger et al. · Blood Advances · 2021 · 70 citations · Full text

CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages

Antonin Papin, Benoît Tessoulin, Céline Bellanger et al. · Leukemia · 2019 · 65 citations

Inflammation, Btk Inhibitions, Lymphoid Neoplasia +13

Multicentric Standardized Flow Cytometry Routine Assessment of Patients With Sepsis to Predict Clinical Worsening

Thomas Daix, Estelle Guérin, Elsa Tavernier et al. · CHEST Journal · 2018 · 60 citations · Full text

Predict Clinical Worsening, Medicine, Acute Care +7

Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Thierry Guillaume, Sylvain Thépot, Pierre Péterlin et al. · Transplantation and Cellular Therapy · 2021 · 43 citations · Full text

Transplantation Medicine, Immunology, Immunotherapy +16